SCHEMBL2911906

SCHEMBL2911906

C[C@H](CO)NC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Br)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
LMNA P02545 1/20 0.34
GSK3B P49841 3/20 0.34
GSK3A P49840 2/20 0.34
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALOX5AP P20292 3/20 0.33
FEN1 P39748 3/20 0.33
FOLH1 Q04609 1/20 0.32
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
CDK1 P06493 1/20 0.31
MAPK1 P28482 5/20 0.31
MAPT P10636 2/20 0.31
POLB P06746 1/20 0.30
CYP3A4 P08684 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904664 1.00 CYP1A2 (0.34) CYP1A2CYP2C19LMNAGSK3BGSK3A
SCHEMBL2909788 0.93 GSK3B (0.34) CYP1A2CYP2C19LMNAGSK3BGSK3A
SCHEMBL2912533 0.93 GSK3B (0.34) CYP1A2CYP2C19LMNAGSK3BGSK3A
SCHEMBL2904127 0.92 MET (0.35) LMNAGSK3BGSK3AALDH1A1SMN1; SMN2
SCHEMBL2910371 0.92 ALDH1A1 (0.41) LMNAGSK3BGSK3AALDH1A1SMN1; SMN2
SCHEMBL2911532 0.92 ALDH1A1 (0.41) LMNAGSK3BGSK3AALDH1A1SMN1; SMN2
SCHEMBL2911193 0.92 MET (0.35) LMNAGSK3BGSK3AALDH1A1SMN1; SMN2
SCHEMBL2911770 0.92 GSK3B (0.34) CYP1A2CYP2C19GSK3BGSK3AALDH1A1
SCHEMBL2913257 0.92 GSK3B (0.34) CYP1A2CYP2C19GSK3BGSK3AALDH1A1
SCHEMBL2910232 0.91 MAPT (0.34) LMNAGSK3BGSK3AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed